Research
Deutsche Bank Downgrades Argenx to Hold, Lifts PT
Deutsche Bank on Monday downgraded immunology company Argenx (ARGX.BR) to hold from buy and increased its price target to 925 euros from 900 euros.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)
$ARGX.BR
